<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Synthetic-Menthol-Flavor-Fragrance-Formulation on Bioecon</title><link>https://en.bioecon.ru/technologies/synthetic-menthol-flavor-fragrance-formulation/</link><description>Recent content in Synthetic-Menthol-Flavor-Fragrance-Formulation on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 21 Jul 2026 15:01:02 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/synthetic-menthol-flavor-fragrance-formulation/index.xml" rel="self" type="application/rss+xml"/><item><title>Biosynthetic menthol</title><link>https://en.bioecon.ru/technology/biosynthetic-menthol/</link><pubDate>Tue, 21 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-menthol/</guid><description>L-menthol supply in 2026 is dominated by conventional routes under active capacity expansion — BASF&amp;rsquo;s triple-digit-million-euro world-scale menthol/linalool plant at Ludwigshafen (Apr 2026) and Symrise&amp;rsquo;s 50-year synthetic-menthol franchise in the EU, alongside NMPA-licensed API extraction (Huangshan Tianmu Mint Pharmaceutical, license renewed to 2030) and food-grade dispersion formulation (Jiangsu Caiwei, 0.001-0.5% precision dosing) in China — while dedicated fermentation-route biosynthesis remains at the academic/patent stage with no company-specific commercial originator confirmed.</description></item></channel></rss>